These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 27058859)
1. Preventing Cardiovascular Disease in Patients With Diabetes: New Evidence Informs Changes in Standards of Care. Worel JN; Hayman LL J Cardiovasc Nurs; 2016; 31(3):198-200. PubMed ID: 27058859 [No Abstract] [Full Text] [Related]
2. The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes. Zhang Y; Vitry A; Caughey G; Roughead EE; Ryan P; Gilbert A; Shakib S; McDermott R Diabetes Res Clin Pract; 2011 Jan; 91(1):115-20. PubMed ID: 21067836 [TBL] [Abstract][Full Text] [Related]
5. Editorial: Cardiovascular and renal 2020: Cardiovascular protection by antidiabetic drugs: Key mechanisms and current clinical data. Gorr MW; Wold LE Curr Opin Pharmacol; 2020 Oct; 54():vii-ix. PubMed ID: 33357715 [No Abstract] [Full Text] [Related]
6. Cardiologists and the management of blood sugar: a Chinese perspective. Hu DY; Guo YF Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):509. PubMed ID: 18719711 [No Abstract] [Full Text] [Related]
7. Focus on metformin - a major cardiovascular medication. 'Diabesity - the biggest epidemic in human history'. Straughan JL Cardiovasc J Afr; 2007; 18(5):331-3. PubMed ID: 17985034 [No Abstract] [Full Text] [Related]
8. [Metabolically designed treatments: from biochemistry to the vessel lining]. Moulin P Rev Med Interne; 2007 Jun; 28 Suppl 1():S12-3. PubMed ID: 17466416 [No Abstract] [Full Text] [Related]
9. [Anti-diabetic therapy and cardiovascular disease]. Mannucci E G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):3s-4. PubMed ID: 27030117 [No Abstract] [Full Text] [Related]
10. Endothelial dysfunction and cardiovascular disease--the lull before the storm. Marx N; Grant PJ Diab Vasc Dis Res; 2007 Jun; 4(2):82-3. PubMed ID: 17654440 [No Abstract] [Full Text] [Related]
11. Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologist. Davidson MH Am J Cardiol; 2012 Nov; 110(9 Suppl):43B-49B. PubMed ID: 23062566 [TBL] [Abstract][Full Text] [Related]
12. The impact of insulin resistance on endothelial function, progenitor cells and repair. Cubbon RM; Rajwani A; Wheatcroft SB Diab Vasc Dis Res; 2007 Jun; 4(2):103-11. PubMed ID: 17654443 [TBL] [Abstract][Full Text] [Related]
13. Strategies for the development of new PPAR agonists in diabetes. Cavender MA; Nicholls SJ; Lincoff AM Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S32-7. PubMed ID: 20489419 [TBL] [Abstract][Full Text] [Related]
15. Incretin therapy for type 2 diabetes mellitus. Klonoff DC Adv Ther; 2010 Dec; 27(12):881-94. PubMed ID: 20978879 [TBL] [Abstract][Full Text] [Related]
16. Diabetes management: More than just cardiovascular risk? Zimmerman RS; Pantalone KM Cleve Clin J Med; 2014 Nov; 81(11):672-6. PubMed ID: 25368217 [No Abstract] [Full Text] [Related]
17. Glycemic management of type 2 diabetes: how tight is right and how to get there. Nathan DM Arch Intern Med; 2008 Oct; 168(19):2064-6. PubMed ID: 18955633 [No Abstract] [Full Text] [Related]
18. Glycemic control and cardiovascular mortality. Riddle MC Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):104-9. PubMed ID: 21522000 [TBL] [Abstract][Full Text] [Related]